Investor presentation
Verici Dx plc will host a live online investor presentation on Wednesday, July 8, 2026, at 16:30 BST to discuss its final results announced on June 29, 2026, and a recent fundraise. The presentation, accessible via Investor Meet Company, is open to all shareholders and potential investors, with opportunities to submit questions before and during the event.
Select text to share a quote on X · sign in to keep highlights & notes in your VRCI notes
Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, will provide a live online presentation relating to the Company's final results announced on 29 June 2026, and recent fundraise, via Investor Meet Company at 16:30 BST on Wednesday 8 July 2026.
Investors can sign up to Investor Meet Company for free and add to meet Verici Dx plc via: https://www.investormeetcompany.com/verici-dx-plc/register-investor
Investors who already follow Verici Dx plc on the Investor Meet Company platform will automatically be invited.
| Verici Dx plc | www.vericidx.com |
| Sara Barrington, CEO | Via Walbrook PR |
| Singer Capital Markets (Nominated adviser, Joint Broker) | Tel: +44 (0)20 7496 3000 |
| Alex Bond / Russell Cook / Jalini Kalaravy | |
| Oberon Capital (Joint Broker) | Tel: +44 (0)20 3179 0500 |
| Mike Seabrook / Adam Pollock | |
| Walbrook PR (Media & Investor Relations) | Tel: +44 (0)20 7933 8780 or vericidx@walbrookpr.com |
| Alice Woodings / Rachel Broad | Mob: +44 (0)7407 804 654 / +44 (0)7747 515 393 |
Verici Dx
The company is UK headquartered in Cardiff for the UK, and in Franklin, Tennessee for the U.S.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.